Sotera Health (SHC) Set to Announce Earnings on Tuesday

Sotera Health (NASDAQ:SHC) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 5th. Analysts expect the company to announce earnings of $0.17 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. The company had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.19 earnings per share. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Sotera Health Stock Performance

Shares of SHC opened at $15.86 on Monday. The company’s 50 day simple moving average is $15.95 and its 200-day simple moving average is $13.61. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The firm has a market cap of $4.49 billion, a PE ratio of 113.29 and a beta of 2.08. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SHC. Royal Bank of Canada restated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Tuesday, August 6th. Barclays increased their target price on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 6th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.70.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 55.12% of the stock is currently owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.